Tolebrutinib was found to delay disability progression in people with nonrelapsing secondary progressive MS in a Phase 3 clinical trial.

Dental treatment unlike your GP is not free and can set you back hundreds of pounds but some people do not have to pay ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

Using eye-tracking—a technique for recording and analyzing eye movements—a team from the University of Geneva (UNIGE) has ...

Using eye-tracking - a technique for recording and analysing eye movements - a team from the University of Geneva (UNIGE) has shown that individuals with multiple disabilities can improve their social ...

Three people with multiple learning disabilities will star in a new photographic display later this month.David Bache, Kenny Oates and Parmi Banga, from Wolverhampton, have taken part in the Front and ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

The New England Journal of Medicine published results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability ...

No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

Musk, seemingly in charge of these decisions, has a net worth of over $360 billion. Unlike working class Americans, he ...

The lawsuit said state Youth Development Center staff used restraints excessively, including as cover for assaults that left kids bruised and battered — once with a shattered orbital bone.